CN102813899A - Medicament for treating intractable vertigo - Google Patents

Medicament for treating intractable vertigo Download PDF

Info

Publication number
CN102813899A
CN102813899A CN2012102942037A CN201210294203A CN102813899A CN 102813899 A CN102813899 A CN 102813899A CN 2012102942037 A CN2012102942037 A CN 2012102942037A CN 201210294203 A CN201210294203 A CN 201210294203A CN 102813899 A CN102813899 A CN 102813899A
Authority
CN
China
Prior art keywords
restrains
gram
rhizoma
medicine
grams
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2012102942037A
Other languages
Chinese (zh)
Inventor
王济见
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2012102942037A priority Critical patent/CN102813899A/en
Publication of CN102813899A publication Critical patent/CN102813899A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a medicament for treating intractable vertigo, and relates to the technical field of traditional Chinese medicine. The medicament is prepared from the following raw materials: 25-35 g of Pogostemon cablin, 25-35 g of bighead atractylodes rhizome, 25-35 g of gastrodia elata, 25-35 g of Poria cocos, 8-16 g of orange peel, 8-16 g of licorice, 4-8 g of bamboo shavings, 4-8 g of Pinellia ternata, 4-8 g of ginger and 4-8 g of Chinese-date. The invention has the following beneficial effects: 1. the medicament has good treatment effect, and is proved to have a total effective rate of 98.2% by 56 clinical trial cases; 2. the manufacturing method is simple and convenient for production; and 3.the low-cost medicament is easily accepted by patients.

Description

A kind of medicine of treating intractable vertigo disease
Technical field
The present invention relates to technical field of Chinese medicines, further is a kind of Chinese medicine medicine that is used to treat intractable vertigo disease.
Background technology
Vertigo is a kind of clinically common symptom.The lighter was as sitting journey when the patient showed effect, and the time of outbreak is of short duration, and the flat order that closes for sleeping in is promptly pacified a moment; Weight person usually can feel dizzy, and can't stand, even fall in a swoon; Vexed with deafness, tinnitus, ear, even feel sick, vomit, emit the symptom of vegetative dystonie such as cold sweat, pale complexion, extremity is ice-cold.
Motherland's medical science thinks, dizzy can being caused by wind, expectorant, wet, void is so there is the saying of " calm do not do dizzy ", " dizziness must be caused by phlegm ", " dizziness must be due to deficiency ".Clinically, can carry out determination of treatment based on pathogenesis obtained through differentiation of symptoms and signs to it according to the dizzy type of patient.Many because the patient's eating and drinking without temperance of intractable vertigo, impairing the spleen and stomach, dysfunction of the spleen in transportation makes transportation and transformation of water and food not normal, and wet gathering and give birth to expectorant, Jiao makes clear YANG failing to ascend, turbid YIN failing to descend and falls ill in the stagnation of phlegm.The quickening of Along with people's rhythm of life, stress increases, environmental pollution in addition, improper diet and motion shortcoming etc., increasing day by day appears in intractable vertigo disease, influences the healthy of people.
Therefore, research and develop out the novel drugs of treatment intractable vertigo disease, have active operation significance with good therapeutic effect.
Summary of the invention
The purpose of this invention is to provide a kind of medicine of treating intractable vertigo disease, it is that raw material is processed with the Chinese herbal medicine, and therapeutic effect is good, taking convenience, and cost is lower.
The objective of the invention is to realize through following scheme:
A kind of medicine of treating intractable vertigo disease; It is characterized in that it being to be processed by following raw material: Herba Pogostemonis 25-35 gram, Rhizoma Atractylodis Macrocephalae 25-35 gram, Rhizoma Gastrodiae 25-35 gram, Poria 25-35 gram, Pericarpium Citri tangerinae 8-16 gram, Radix Glycyrrhizae 8-16 gram, Caulis Bambusae In Taenia 4-8 gram, Rhizoma Pinelliae 4-8 gram, Rhizoma Zingiberis Recens 4-8 gram, Fructus Jujubae 4-8 gram during making, can be made into pharmaceutical dosage form commonly used; Like powder; Pill, capsule, one of decoction.
The present invention also can further realize through following scheme:
When said making powder or pill or capsule, each raw material pulverizing is crossed 60 orders-80 mesh sieve, mix homogeneously is processed powder or pill or capsule and is got final product.
During said making decoction, intense fire boils back slow fire to be fried in shallow oil slowly, to surplus 1/3 o'clock of water, removes fiery filtering residue.
Among the present invention:
Herba Pogostemonis, Pericarpium Citri tangerinae, Poria, the Rhizoma Pinelliae, Rhizoma Zingiberis Recens removing dampness and eliminating phlegm are monarch drug, and the Rhizoma Atractylodis Macrocephalae, Fructus Jujubae invigorating the spleen to clear away damp pathogen are ministerial drug, and the Rhizoma Gastrodiae endogenous wind-evil caused by sthenic liver-energy) is an adjuvant drug, and Radix Glycyrrhizae, Caulis Bambusae In Taenia moistening are mended and be messenger drug.All medicines are harmonious, and form the effect of removing dampness and eliminating phlegm, invigorating the spleen and regulating the stomach, fixed dizzy relieving fainting altogether.
The beneficial effect of medicine according to the invention is: 1, therapeutic effect is good.Show that through 56 routine clinical trials total effective rate is 98.2%.2, manufacture method is simple, is convenient to produce.3, cost is low, and the patient is easy to accept.
Below, further set forth the beneficial effect of medicine according to the invention through the clinical observation on the therapeutic effect test.
Testing data:
1, cure mainly: phlegm-damp is stranded the gastric pattern vertigo, like dizzy pupil, very dizzy, top-heavy, uncomfortable in chest vomiting, and the lack of appetite drowsirness, health is sleepy, myasthenia of limbs, prolonged difficulty is more.Main clinical manifestation is: dizzy nose heave, chest and diaphragm is full vexed, nausea and vomiting, and anorexia, limbs are heavy, white and greasy fur, soft pulse is sliding.
2, case statistics: treat 56 examples, among the patient, male's 27 examples, women's 29 examples, age distribution is: 4 examples below 30 years old, 31~40 years old 12 example, 41~50 years old 13 example, 51~60 years old 17 example, 10 examples more than 60 years old, maximum age 67 years old, minimal ages 18 years old.
3, Therapeutic Method: once-a-day, restrain or 250 milliliters for a time 3.
4, efficacy assessment standard:
Cure: dizzy and other transference cures, the auxiliary examination index is basic normal or approaching normal, and drug withdrawal is observed did not have recurrence in 3 months.
Take a turn for the better: cardinal symptom such as dizzy is obviously improved or cardinal symptom such as dizzy disappears, but idol has slight recidivist's auxiliary treatment to take a turn for the better after the drug withdrawal.
Invalid: dizzy and other symptoms do not have improvement or increase the weight of.
5, therapeutic effect:
21 days is a course of treatment, normally takes 3 courses of treatment continuously.Cure 34 examples, account for 60.7%, 21 examples that take a turn for the better account for 37.5%, and invalid 1 example accounts for 1.8%, total effective rate 98.2%.
6, model case introduction:
Case 1: Chen, the woman, 69 years old, Ma Chengjing people from village pressed down in Hua County, Henan Province through the ages, suffered from the intractable vertigo disease several years, sought medical advice in many ways and do not feel any better, and go to a doctor in April, 2011, and symptom is dizzy, and tinnitus is uncomfortable in chest, unsets, annual recurrence, transfusion alleviates, and drug withdrawal is still; Take recovery from illness 1 course of treatment of this medicine, follow up a case by regular visits to stablely, do not have recurrence.
Case 2: tall certain, the man, 43 years old, eastern Qiao Zhuan people was pressed down in Hua County, Henan Province through the ages, suffered from vertigo 1 year, sought medical advice in many ways and did not feel any better, go to a doctor in JIUYUE, 2004, symptom is dizzy, feels sick, and is very dizzy when serious, the recovery from illness 1 course of treatment of this medicine is taken in vomiting, follows up a case by regular visits to stablely, does not have recurrence.
Case 3: Lu, the man, 39 years old, people from Guzhen stayed in Hua County in Henan Province, suffered from vertigo half a year, sought medical advice in many ways and do not feel any better, and go to a doctor in May, 2012, and symptom is top-heavy, and difficulty in walking is taken the recovery from illness 1 course of treatment of this medicine, follows up a case by regular visits to stablely, does not have recurrence.
The specific embodiment
In order to make those skilled in the art person understand the present invention program better, and make above-mentioned purpose of the present invention, feature and advantage can be more obviously understandable, below in conjunction with embodiment the present invention done further detailed explanation.
Embodiment 1:
A kind of medicine of treating intractable vertigo disease; Processed by following raw material: Herba Pogostemonis 25 grams, the Rhizoma Atractylodis Macrocephalae 25 grams, Rhizoma Gastrodiae 25 grams, Poria 25 grams, Pericarpium Citri tangerinae 8 grams, Radix Glycyrrhizae 8 grams, Caulis Bambusae In Taenia 4 grams, the Rhizoma Pinelliae 4 grams, Rhizoma Zingiberis Recens 4 grams, Fructus Jujubae 4 grams during making, can be made into pharmaceutical dosage form commonly used; Like powder; Pill, capsule, one of decoction.
Embodiment 2:
A kind of medicine of treating intractable vertigo disease; Processed by following raw material: Herba Pogostemonis 35 grams, the Rhizoma Atractylodis Macrocephalae 35 grams, Rhizoma Gastrodiae 35 grams, Poria 35 grams, Pericarpium Citri tangerinae 16 grams, Radix Glycyrrhizae 16 grams, Caulis Bambusae In Taenia 8 grams, the Rhizoma Pinelliae 8 grams, Rhizoma Zingiberis Recens 8 grams, Fructus Jujubae 8 grams during making, can be made into pharmaceutical dosage form commonly used; Like powder; Pill, capsule, one of decoction.
Embodiment 3:
A kind of medicine of treating intractable vertigo disease; Processed by following raw material: Herba Pogostemonis 30 grams, the Rhizoma Atractylodis Macrocephalae 30 grams, Rhizoma Gastrodiae 30 grams, Poria 30 grams, Pericarpium Citri tangerinae 12 grams, Radix Glycyrrhizae 12 grams, Caulis Bambusae In Taenia 6 grams, the Rhizoma Pinelliae 6 grams, Rhizoma Zingiberis Recens 6 grams, Fructus Jujubae 6 grams during making, can be made into pharmaceutical dosage form commonly used; Like powder; Pill, capsule, one of decoction.
Embodiment 4:
A kind of medicine of treating intractable vertigo disease; It is characterized in that it being to be processed by following raw material: Herba Pogostemonis 35 grams, the Rhizoma Atractylodis Macrocephalae 25 grams, Rhizoma Gastrodiae 25 grams, Poria 25 grams, Pericarpium Citri tangerinae 8 grams, Radix Glycyrrhizae 8 grams, Caulis Bambusae In Taenia 8 grams, the Rhizoma Pinelliae 4 grams, Rhizoma Zingiberis Recens 4 grams, Fructus Jujubae 4 grams during making, can be made into pharmaceutical dosage form commonly used; Like powder; Pill, capsule, one of decoction.
When said making powder or pill or capsule, each raw material pulverizing is crossed 60 orders-80 mesh sieve, mix homogeneously is processed powder or pill or capsule and is got final product.Described pill can be a kind of of the watered pill, honeyed pill.
When said making electuary or lotion, intense fire boils back slow fire to be fried in shallow oil slowly, to water surplus 1/3 o'clock, removes fiery filtering residue.
The above; Be merely the specific embodiment of the present invention, but protection scope of the present invention is not limited thereto, any technical staff who is familiar with the present technique field is in the technical scope that the present invention discloses; The variation that can expect easily or replacement all should be encompassed within protection scope of the present invention.

Claims (5)

1. medicine of treating intractable vertigo disease; It is characterized in that it being to be processed by following raw material: Herba Pogostemonis 25-35 gram, Rhizoma Atractylodis Macrocephalae 25-35 gram, Rhizoma Gastrodiae 25-35 gram, Poria 25-35 gram, Pericarpium Citri tangerinae 8-16 gram, Radix Glycyrrhizae 8-16 gram, Caulis Bambusae In Taenia 4-8 gram, Rhizoma Pinelliae 4-8 gram, Rhizoma Zingiberis Recens 4-8 gram, Fructus Jujubae 4-8 gram during making, can be made into pharmaceutical dosage form commonly used; Like powder; Pill, capsule, one of decoction.
2. the medicine of treatment intractable vertigo disease according to claim 1, it is characterized in that it being that the raw material composition is: Herba Pogostemonis 30 restrains, the Rhizoma Atractylodis Macrocephalae 30 restrains, Rhizoma Gastrodiae 30 restrains, Poria 30 restrains, Pericarpium Citri tangerinae 12 restrains, Radix Glycyrrhizae 12 restrains, Caulis Bambusae In Taenia 6 restrains, the Rhizoma Pinelliae 6 restrains, Rhizoma Zingiberis Recens 6 restrains, Fructus Jujubae 6 restrains.
3. the medicine of treatment refractory skin according to claim 1 and 2, it is characterized in that it being that the raw material composition is: Herba Pogostemonis 35 restrains, the Rhizoma Atractylodis Macrocephalae 25 restrains, Rhizoma Gastrodiae 25 restrains, Poria 25 restrains, Pericarpium Citri tangerinae 8 restrains, Radix Glycyrrhizae 8 restrains, Caulis Bambusae In Taenia 8 restrains, the Rhizoma Pinelliae 4 restrains, Rhizoma Zingiberis Recens 4 restrains, Fructus Jujubae 4 restrains.
4. the medicine of treatment refractory skin according to claim 1 is characterized in that: when said making powder or pill or capsule, each raw material pulverizing is crossed 60 orders-80 mesh sieve, mix homogeneously is processed powder or pill or capsule and is got final product.
5. the medicine of treatment refractory skin according to claim 1 is characterized in that: when said making electuary or lotion, intense fire boils back slow fire to be fried in shallow oil slowly, to water surplus 1/3 o'clock, removes fiery filtering residue.
CN2012102942037A 2012-08-18 2012-08-18 Medicament for treating intractable vertigo Pending CN102813899A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2012102942037A CN102813899A (en) 2012-08-18 2012-08-18 Medicament for treating intractable vertigo

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2012102942037A CN102813899A (en) 2012-08-18 2012-08-18 Medicament for treating intractable vertigo

Publications (1)

Publication Number Publication Date
CN102813899A true CN102813899A (en) 2012-12-12

Family

ID=47298581

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2012102942037A Pending CN102813899A (en) 2012-08-18 2012-08-18 Medicament for treating intractable vertigo

Country Status (1)

Country Link
CN (1) CN102813899A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103341143A (en) * 2013-07-09 2013-10-09 陈静静 Traditional Chinese medicine for treating insomnia
CN104383506A (en) * 2014-12-06 2015-03-04 唐云峰 Traditional Chinese medicine composition for treating dizziness

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
周艳芳等: "半夏白术天麻汤治疗眩晕100例临床观察", 《内蒙古中医药》 *
梁国权: "藿香正气散治疗湿浊眩晕150例疗效观察", 《辽宁中医学院学报》 *
罗佩杰等: "半夏白术天麻汤治疗眩晕100例临床观察", 《中医临床研究》 *
罗文: "半夏白术天麻汤治疗痰湿型眩晕48例", 《中外医疗》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103341143A (en) * 2013-07-09 2013-10-09 陈静静 Traditional Chinese medicine for treating insomnia
CN104383506A (en) * 2014-12-06 2015-03-04 唐云峰 Traditional Chinese medicine composition for treating dizziness

Similar Documents

Publication Publication Date Title
CN101757568B (en) Traditional Chinese medicine composition for treating insomnia and preparation method thereof
CN101698090B (en) Traditional Chinese medicine composite for treating coma and heart syncope symptoms and preparation method thereof
CN102283999B (en) Traditional Chinese medicine preparation for treating insomnia
CN101766802B (en) Chinese medicine composite for treatment of acute gastroenteritis and preparation method thereof
CN103432475B (en) Traditional Chinese medicine composition for treating allergic rhinitis and preparation method thereof
CN102335330B (en) Traditional Chinese medicine composition for treating insomnia
CN101773622A (en) Chinese medicinal composition for treating night sweats and preparation method thereof
CN101797352B (en) Chinese medicinal composition for treating lassitude hypodynamia and preparation method thereof
CN102198241A (en) Medicine for alleviating nervousness and taking care of sub-health
CN101773632B (en) Chinese medicine composition for treating dizziness and preparation method thereof
CN101810792B (en) Chinese medicinal composition for treating kidney failure diseases and preparation method thereof
CN103405728A (en) Traditional Chinese medicine composition for treating climacteric syndrome and preparation method thereof
CN101773621B (en) Chinese medicine for treating spontaneous sweating and preparation method thereof
CN102836412B (en) Chinese medicinal composition for treating idiopathic facial paralysis and preparation method thereof
CN104225194A (en) Traditional Chinese medicine for treating insomnia
CN101810787B (en) Chinese medicinal composition for treating dysphoria and preparation method thereof
CN103251796B (en) Traditional Chinese medicine for treating insomnia
CN101884779A (en) Siberian solomonseal rhizome composition for intervening sub-health state and preparation method thereof
CN102813899A (en) Medicament for treating intractable vertigo
CN101890142A (en) Chinese medicinal composition for curing somnolence and preparation method thereof
CN102908396A (en) Chinese medicinal composition for promoting sleeping and preparation method thereof
CN102091247B (en) Traditional Chinese medicine composition for treating coronary heart disease
CN101716321A (en) Traditional Chinese medicine composition for treating heart vessel blockage stasis disease and preparation method thereof
CN107595998B (en) Traditional Chinese medicine composition for stroke convalescence and preparation method thereof
CN102327410A (en) Traditional Chinese medicine composition for treating epigastric fullness

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20121212